Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Rydén L, et al. Among authors: standl e. Eur Heart J. 2007 Jan;28(1):88-136. doi: 10.1093/eurheartj/ehl260. Eur Heart J. 2007. PMID: 17220161 No abstract available.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Among authors: standl e. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.
Bartnik M, Rydén L, Malmberg K, Ohrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J; Euro Heart Survey Investigators. Bartnik M, et al. Among authors: standl e. Heart. 2007 Jan;93(1):72-7. doi: 10.1136/hrt.2005.086975. Epub 2006 Aug 11. Heart. 2007. PMID: 16905628 Free PMC article.
[Guidelines on diabetes, pre-diabetes, and cardiovascular diseases].
Grupo de Trabajo sobre Diabetes y Enfermedades Cardiovasculares de la Sociedad Europea de Cardiología y de la Sociedad Europea para el Estudio de la Diabetes; Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I. Grupo de Trabajo sobre Diabetes y Enfermedades Cardiovasculares de la Sociedad Europea de Cardiología y de la Sociedad Europea para el Estudio de la Diabetes, et al. Among authors: standl e. Rev Esp Cardiol. 2007 May;60(5):1e-64e. Rev Esp Cardiol. 2007. PMID: 17535764 Spanish. No abstract available.
Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).
Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA; PROactive Investigators. Erdmann E, et al. Among authors: standl e. Diabetes Care. 2007 Nov;30(11):2773-8. doi: 10.2337/dc07-0717. Epub 2007 Jul 31. Diabetes Care. 2007. PMID: 17666462 Clinical Trial.
Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart.
Anselmino M, Ohrvik J, Malmberg K, Standl E, Rydén L; Euro Heart Survey Investigators. Anselmino M, et al. Among authors: standl e. Eur Heart J. 2008 Jan;29(2):177-84. doi: 10.1093/eurheartj/ehm519. Epub 2007 Dec 21. Eur Heart J. 2008. PMID: 18156611
[Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary].
Rydén L, Standl E, Bartnik Mg, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I; Grupo de trabalho da European Society of Cardiology; European Association for the Study of Diabetes. Rydén L, et al. Among authors: standl e. Rev Port Cardiol. 2007 Nov;26(11):1213-74. Rev Port Cardiol. 2007. PMID: 18297842 Review. Portuguese. No abstract available.
On the potential of acarbose to reduce cardiovascular disease.
Standl E, Theodorakis MJ, Erbach M, Schnell O, Tuomilehto J. Standl E, et al. Cardiovasc Diabetol. 2014 Apr 16;13:81. doi: 10.1186/1475-2840-13-81. Cardiovasc Diabetol. 2014. PMID: 24742256 Free PMC article. Review.
Current perspectives on cardiovascular outcome trials in diabetes.
Schnell O, Rydén L, Standl E, Ceriello A; D&CVD EASD Study Group. Schnell O, et al. Among authors: standl e. Cardiovasc Diabetol. 2016 Oct 1;15(1):139. doi: 10.1186/s12933-016-0456-8. Cardiovasc Diabetol. 2016. PMID: 27716274 Free PMC article. Review.
299 results